- Many institutions are finding it common to mix ipratropium bromide with albuterol and give the combined medications to the patient via the nebulizer.
- It is believed that these two medications have a synergistic effect that causes an increase in bronchodilation.
- The onset of action of Ipratropium occurs in 90 minutes, and albuterol begins working in 5 minutes [13].
- Combivent Inhalation Aerosol will not be available after December 31, 2013 secondary to the use of CFCs as a propellant
- The FDA has approved Combivent Respimat (ipratropium bromide and albuterol sulfate) Inhalation which does not use CFCs
| | | | |